SEP 24, 2018 7:56 PM PDT

Pain Management Drug Found Ineffective in Traumatic Injury Patients

WRITTEN BY: Nouran Amin

Image via Scientific American

Driven by the effort to identify effective non-opioid pain medications, a recent international research study with a publication in the Journal Neurology, found that the drug ‘pregabalin’ is not effective in treating chronic pain associated with traumatic nerve injury. "The unrelenting burning or stabbing symptoms due to nerve trauma are a leading reason why people seek treatment for chronic pain after a fall, car accident, or surgery," explains John Markman, M.D., director of the Translational Pain Research Program in the University of Rochester Department of Neurosurgery and lead author of the study. "While these finding show that pregabalin is not effective in controlling the long-term pain for traumatic injury, it may provide relief for patients experience post-surgical pain."

Watch Video Below To Learn More About Traumatic Brain Injury:

Marketed under Pfizer, Pregabalin is under the name Lyrica and is approved to treat chronic pain associated with shingles, spinal cord injury, fibromyalgia, and diabetic peripheral neuropathy. But, is commonly a prescription drug for treating chronic nerve injury syndromes that occur after motor vehicle accidents, falls, sports injuries, knee or hip replacement and as well as surgeries that include hernia repair or mastectomy. Previously, an eight-week study showed that pregabalin decreased pain intensity better than placebo in chronic, post-traumatic pain syndromes. The findings resulted in many doctors to prescribe pregabalin for long-term pain that takes a while to resolve.

The present study, consisting of a retrospective analysis, found that pregabalin did not hold high efficacy for pain management in individuals with traumatic nerve injury. "The possibility that there was pain relief for those patients who had a hernia repair, or breast surgery for cancer, or a joint replacement lays the groundwork for future studies in these post-surgical syndromes where there is so much need for non-opioid treatments," says Markman. "Given the rising rates of surgery and shrinking reliance on opioids, it is critical that we understand how to study new drugs that work differently in patients like the ones included in this study.”

Source: University of Rochester Medical Center

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Drug Combo Targets Osteoarthritis
Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, s...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Should You Really be Scared of the Coronavirus?
As of February 21st, the death toll for coronavirus reached 2,250, 55,707 currently infected, of which 12,066 (22%) are in a serious or critical condition....
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: having an anti-inflammatory effect on lu...
Loading Comments...